Form D · Biotechnology
Adze Biotechnology Inc
Coral Gables, FL · CIK 0001787508
Offering snapshot reported Nov 17, 2025 · SEC filing
- Reported sold
- $6.15M Offering amount: $15M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 10, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$6,149,998 → $6,150,005
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 17, 2025 | Amendment | $6,150,005 | $7vs Feb 19, 2025 | 21 | SEC filing |
| Feb 19, 2025 | Amendment | $6,149,998 | $0vs Feb 22, 2024 | 21 | SEC filing |
| Feb 22, 2024 | Amendment | $6,149,998 | $0vs Mar 14, 2023 | 21 | SEC filing |
| Mar 14, 2023 | Initial | $6,149,998 | No comparison | 21 | SEC filing |
| May 19, 2022 | Amendment | $3,687,500 | $1,130,000vs Nov 19, 2021 | 19 | SEC filing |
| Nov 19, 2021 | Amendment | $2,557,500 | $557,500vs Mar 31, 2021 | 9 | SEC filing |
| Mar 31, 2021 | Amendment | $2,000,000 | $0vs Dec 14, 2020 | 5 | SEC filing |
| Dec 14, 2020 | Amendment | $2,000,000 | $1,000,000vs Dec 19, 2019 | 5 | SEC filing |
| Dec 19, 2019 | Amendment | $1,000,000 | No comparison | 4 | SEC filing |
| Sep 9, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-475802
Source: Form D, filed Nov 17, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sidney Hopps | Director, Executive |
| Brendan Kenny | Director |
| Gloria Olivier | Director |
| Gabriel Raviv | Director |
| G. Patrick Sage | Director |
| Patrick G. Sage, Ii | Director |
| G. Patrick Sage, Ii | Director |
| Richard Schuler | Director |
| Kenneth J. Templin | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2332 Galiano Street, 2 Nd Fl
Coral Gables, FL, 33134
Coral Gables, FL, 33134